BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/17/2020 5:41:30 AM | Browse: 688 | Download: 564
 |
Received |
|
2020-02-08 07:43 |
|
Peer-Review Started |
|
2020-02-08 07:44 |
|
To Make the First Decision |
|
2020-02-17 09:28 |
|
Return for Revision |
|
2020-02-17 09:31 |
|
Revised |
|
2020-03-03 00:31 |
|
Second Decision |
|
2020-03-19 13:01 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-03-22 20:56 |
|
Articles in Press |
|
2020-03-22 20:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-04-13 10:23 |
|
Publish the Manuscript Online |
|
2020-04-17 05:41 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Editorial |
| Article Title |
Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rajesh R Tampi, Pallavi Joshi, Padmapriya Marpuri and Deena J Tampi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rajesh R Tampi, MD, Chairman, Department of Psychiatry and Behavioral Sciences, Cleveland Clinic Akron General, Akron, OH 44106, United States. rajesh.tampi@yale.edu |
| Key Words |
Dextromethorphan; Quinidine; Agitation; Dementia; Behavioral and psychological symptoms of dementia; |
| Core Tip |
Dextromethorphan-quinidine is approved for the treatment of pseudobulbar affect and may be effective in managing agitation in dementia. There is only one published trial that has evaluated the use dextromethorphan-quinidine for agitation in dementia. The study was of good quality and found that dextromethorphan-quinidine decreases severity of agitation when compared to placebo. Additionally, dextromethorphan-quinidine was fairly well tolerated and did not appear to cause significant sedation or worsen cognitive symptoms among individuals with dementia. |
| Publish Date |
2020-04-17 05:41 |
| Citation |
Tampi RR, Joshi P, Marpuri P, Tampi DJ. Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia. World J Psychiatr 2020; 10(4): 29-33 |
| URL |
https://www.wjgnet.com/2220-3206/full/v10/i4/29.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v10.i4.29 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
